| |
| |
|
| Insider
Information: |
Brockstedt Dirk G. |
| Relationship: |
|
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
152,423 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,150,811 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
152,423 |
|
|
| Total
Value |
$5,150,811 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -104.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chinook Therapeutics Inc |
KDNY |
EVP of Research and Dev. |
2017-12-29 |
124,603 |
2015-11-16 |
0 |
Premium* |
|
|
Rapt Therapeutics, Inc. |
RAPT |
|
2024-01-05 |
27,820 |
2020-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-11-16 |
4 |
AS |
$27.50 |
$204,294 |
D/D |
(7,423) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-11-16 |
4 |
OE |
$0.45 |
$2,679 |
D/D |
5,953 |
7,423 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-11-17 |
4 |
AS |
$27.78 |
$545,734 |
D/D |
(19,047) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-11-17 |
4 |
OE |
$0.45 |
$13,220 |
D/D |
19,047 |
19,047 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-12-10 |
4 |
AS |
$29.43 |
$745,423 |
D/D |
(25,000) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-12-10 |
4 |
OE |
$1.45 |
$36,250 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2015-12-16 |
4 |
OE |
$1.45 |
$17,400 |
D/D |
12,000 |
12,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2016-01-11 |
4 |
AS |
$21.57 |
$479,015 |
D/D |
(22,000) |
12,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2016-01-11 |
4 |
OE |
$0.45 |
$10,856 |
D/D |
22,000 |
33,044 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2016-05-16 |
4 |
AS |
$8.20 |
$7,421 |
D/D |
(905) |
12,000 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. VP of Research and Dev. |
• – – |
2016-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
37,300 |
49,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-01-17 |
4 |
AS |
$11.86 |
$94,858 |
D/D |
(8,000) |
49,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-01-17 |
4 |
OE |
$0.45 |
$3,600 |
D/D |
8,000 |
57,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-03-09 |
4 |
AS |
$11.00 |
$88,001 |
D/D |
(8,000) |
49,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-03-09 |
4 |
OE |
$0.45 |
$3,600 |
D/D |
8,000 |
57,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-04-03 |
4 |
AS |
$10.71 |
$85,645 |
D/D |
(8,000) |
49,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-04-03 |
4 |
OE |
$0.45 |
$3,600 |
D/D |
8,000 |
57,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-05-11 |
4 |
AS |
$9.72 |
$77,725 |
D/D |
(8,000) |
49,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-05-11 |
4 |
OE |
$0.52 |
$4,160 |
D/D |
8,000 |
57,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-05-17 |
4 |
AS |
$9.65 |
$9,756 |
D/D |
(1,011) |
49,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-06-01 |
4 |
AS |
$10.00 |
$80,020 |
D/D |
(8,000) |
49,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-06-01 |
4 |
OE |
$0.52 |
$4,160 |
D/D |
8,000 |
57,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-07-03 |
4 |
AS |
$11.02 |
$110,167 |
D/D |
(10,000) |
49,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-07-03 |
4 |
OE |
$0.45 |
$4,826 |
D/D |
10,000 |
59,300 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
EVP of Research and Dev. |
• – – |
2017-08-07 |
4 |
OE |
$0.52 |
$5,200 |
D/D |
10,000 |
59,300 |
0 |
- |
|
86 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
